BMS 215 Pill: green, five-sided
Generic Name: daclatasvir
The pill with imprint BMS 215 (Green, Five-sided, 0mm) has been identified as Daklinza 60 mg and is used for Hepatitis C. It belongs to the drug class NS5A inhibitors and is not a controlled substance.
Images for BMS 215
Daklinza
- Generic Name
- daclatasvir
- Imprint
- BMS 215
- Strength
- 60 mg
- Color
- Green
- Shape
- Five-sided
- Availability
- Prescription only
- Drug Class
- NS5A inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 00003-0215 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
croscarmellose sodium,
silicon dioxide,
magnesium stearate,
titanium dioxide,
polyethylene glycol 400,
FD&C Blue No. 2,
indigotindisulfonate sodium,
aluminum oxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
See also:
More about Daklinza (daclatasvir)
- Check interactions
- Compare alternatives
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NS5A inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.